Clinical Trial Update: A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events [Phase 2]

View source ↗

Summary

Phase 2 study evaluating HRS-5346 in adults with elevated lipoprotein(a) at high cardiovascular risk has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hyperlipoproteinemia

Drugs mentioned

• HRS-5346

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Treatment of Lipoprotein Disorder | Phase 2 | Status: COMPLETED